Status:
COMPLETED
Preventing Diabetes
Lead Sponsor:
Geisinger Clinic
Conditions:
PreDiabetes
Eligibility:
All Genders
18-89 years
Phase:
NA
Brief Summary
The purpose of this project is to improve the quality of weight management care for patients with pre-diabetes and overweight or obesity. Personalized risk profiles, clinical decision support, and pat...
Detailed Description
The primary aim of this study was to demonstrate that an increased recruitment rate for weight loss intervention can be achieved within patients that have pre-diabetes by communicating personalized ri...
Eligibility Criteria
Inclusion
- At least two weight measures within the last two 24 months, including most recent, that meet the following criteria:
- Prediabetes and BMI \>27: Treatment Option 1, 2, 3, or 4
- Prediabetes and BMI \>40: Treatment Options 1-5
- Most recent laboratory value that meets prediabetes indicators, per American Diabetes Association, 2016
- Hemoglobin A1C ≥5.7% and \<6.5%, or
- Fasting plasma glucose ≥100 mg/dl and \<126 mg/dl, or
- Oral glucose tolerance test ≥140 mg/dl and \<200 mg/dl
Exclusion
- History of significant weight loss documented within 5 years,
- Contraindications to weight change (e.g., cancer, pregnancy)
- Prior bariatric surgery
- Weight loss medication use or orders within 5 years prior to the project.
Key Trial Info
Start Date :
December 18 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 16 2021
Estimated Enrollment :
84 Patients enrolled
Trial Details
Trial ID
NCT05395377
Start Date
December 18 2017
End Date
November 16 2021
Last Update
May 27 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Geisinger Health System
Danville, Pennsylvania, United States, 17822